Migraine and epilepsy are classified as chronic paroxysmal neurologic disorders sharing many clinical features, as well as possible treatment options. This review highlights the similarities between migraine and epilepsy in pediatrics, focusing on epidemiologic, pathophysiological, genetic, clinical, and pharmacologic aspects. Despite the fact that several syndromes share symptoms of both migraine and epilepsy, further research is needed to clarify the pathophysiological and genetic basis of their comorbidity. Drugs used for prophylactic therapy of migraine and epilepsy have similar pharmacologic properties. The role of epileptic pharmacotherapy in the prophylaxis of migraine is assessed, including the use of conventional antiepileptic drugs, calcium channel blockers, and nonpharmacologic methods such as dietary therapy, supplements, and vagal nerve stimulation. Further randomized, controlled clinical trials assessing pharmacologic and nonpharmacologic methods for the treatment of both disorders are essential, in order to initiate new therapeutic approaches.

Additional Metadata
Keywords children, comorbidity, epilepsy, migraine
Persistent URL dx.doi.org/10.1177/0883073818788942, hdl.handle.net/1765/114328
Journal Journal of Child Neurology
Jancic, J, Djuric, V, Hencic, B, van den Anker, J.N, & Samardzic, J. (2018). Comorbidity of Migraine and Epilepsy in Pediatrics: A Review. Journal of Child Neurology (Vol. 33, pp. 801–808). doi:10.1177/0883073818788942